Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 32

1.

Neutron and hard X-ray diffraction studies of the isothermal transformation kinetics in the research reactor fuel candidate U-8 wt%Mo.

Säubert S, Jungwirth R, Zweifel T, Hofmann M, Hoelzel M, Petry W.

J Appl Crystallogr. 2016 May 16;49(Pt 3):923-933. eCollection 2016 Jun 1.

2.

The Value of Companion Diagnostics: Overcoming Access Barriers to Transform Personalised Health Care into an Affordable Reality in Europe.

Wurcel V, Perche O, Lesteven D, Williams DA, Schäfer B, Hopley C, Jungwirth R, Postulka A, Pasmans R, Hermansson LL, Ott M, Glorioso V.

Public Health Genomics. 2016;19(3):137-43. doi: 10.1159/000446531. Epub 2016 Jun 1.

3.

[Media usage and passive smoking in preschool children: risk factors for cognitive development?].

Winterstein P, Jungwirth RJ.

Kinderkrankenschwester. 2015 Jul;34(7):266-72. German. No abstract available.

PMID:
26314149
4.

Escherichia coli producing a cephamycinase (CMY-2) from a patient from the Libyan---Tunisian border region.

Bauernfeind A, Hohl P, Schneider I, Jungwirth R, Frei R.

Clin Microbiol Infect. 1998 Mar;4(3):168-170. No abstract available.

5.

A novel type of AmpC beta-lactamase, ACC-1, produced by a Klebsiella pneumoniae strain causing nosocomial pneumonia.

Bauernfeind A, Schneider I, Jungwirth R, Sahly H, Ullmann U.

Antimicrob Agents Chemother. 1999 Aug;43(8):1924-31.

6.

Differential autocrine regulation of intestine epithelial cell proliferation and differentiation by insulin-like growth factor (IGF) system components.

Jehle PM, Fussgaenger RD, Blum WF, Angelus NK, Hoeflich A, Wolf E, Jungwirth RJ.

Horm Metab Res. 1999 Feb-Mar;31(2-3):97-102.

PMID:
10226788
7.
8.

Proinsulin stimulates growth of small intestinal crypt-like cells acting via specific receptors.

Jehle PM, Fussgaenger RD, Angelus NK, Jungwirth RJ, Saile B, Lutz MP.

Am J Physiol. 1999 Feb;276(2):E262-8. doi: 10.1152/ajpendo.1999.276.2.E262.

PMID:
9950785
9.

[Imipenem resistance in Pseudomonas aeruginosa].

Fille M, Bauernfeind A, Eberlein E, Jungwirth R, Schneider I, Speer G, Dierich MP, Allerberger F.

Wien Klin Wochenschr. 1998 Oct 30;110(20):715-20. German.

PMID:
9857429
10.

Discrimination of Burkholderia gladioli from other Burkholderia species detectable in cystic fibrosis patients by PCR.

Bauernfeind A, Schneider I, Jungwirth R, Roller C.

J Clin Microbiol. 1998 Sep;36(9):2748-51.

11.

Molecular procedure for rapid detection of Burkholderia mallei and Burkholderia pseudomallei.

Bauernfeind A, Roller C, Meyer D, Jungwirth R, Schneider I.

J Clin Microbiol. 1998 Sep;36(9):2737-41.

12.
13.

Ceftazidime-resistant Enterobacteriaceae isolates from three Polish hospitals: identification of three novel TEM- and SHV-5-type extended-spectrum beta-lactamases.

Gniadkowski M, Schneider I, Jungwirth R, Hryniewicz W, Bauernfeind A.

Antimicrob Agents Chemother. 1998 Mar;42(3):514-20.

14.

A novel class C beta-lactamase (FOX-2) in Escherichia coli conferring resistance to cephamycins.

Bauernfeind A, Wagner S, Jungwirth R, Schneider I, Meyer D.

Antimicrob Agents Chemother. 1997 Sep;41(9):2041-6.

15.

Comparative characterization of the cephamycinase blaCMY-1 gene and its relationship with other beta-lactamase genes.

Bauernfeind A, Stemplinger I, Jungwirth R, Wilhelm R, Chong Y.

Antimicrob Agents Chemother. 1996 Aug;40(8):1926-30.

16.

Characterization of beta-lactamase gene blaPER-2, which encodes an extended-spectrum class A beta-lactamase.

Bauernfeind A, Stemplinger I, Jungwirth R, Mangold P, Amann S, Akalin E, Anğ O, Bal C, Casellas JM.

Antimicrob Agents Chemother. 1996 Mar;40(3):616-20.

17.

Sequences of beta-lactamase genes encoding CTX-M-1 (MEN-1) and CTX-M-2 and relationship of their amino acid sequences with those of other beta-lactamases.

Bauernfeind A, Stemplinger I, Jungwirth R, Ernst S, Casellas JM.

Antimicrob Agents Chemother. 1996 Feb;40(2):509-13.

18.

Characterization of the plasmidic beta-lactamase CMY-2, which is responsible for cephamycin resistance.

Bauernfeind A, Stemplinger I, Jungwirth R, Giamarellou H.

Antimicrob Agents Chemother. 1996 Jan;40(1):221-4.

19.

Comparative pharmacodynamics of clarithromycin and azithromycin against respiratory pathogens.

Bauernfeind A, Jungwirth R, Eberlein E.

Infection. 1995 Sep-Oct;23(5):316-21.

PMID:
8557398
20.

Influence of cholesterol supply on cell growth and differentiation in cultured enterocytes (CaCo-2).

Herold G, Jungwirth R, Rogler G, Geerling I, Stange EF.

Digestion. 1995;56(1):57-66.

PMID:
7895934
21.

Multiclonal emergence of ciprofloxacin-resistant clinical isolates of Escherichia coli and Klebsiella pneumoniae.

Bauernfeind A, Abele-Horn M, Emmerling P, Jungwirth R.

J Antimicrob Chemother. 1994 Dec;34(6):1074-6. No abstract available.

PMID:
7730225
22.

A new plasmidic cefotaximase from patients infected with Salmonella typhimurium.

Bauernfeind A, Casellas JM, Goldberg M, Holley M, Jungwirth R, Mangold P, Röhnisch T, Schweighart S, Wilhelm R.

Infection. 1992 May-Jun;20(3):158-63.

PMID:
1644493
23.

RU 29 246, the active compound of the cephalosporin-prodrug-ester HR 916. II. Stability to beta-lactamases and affinity for penicillin-binding proteins.

Markus A, Klesel N, Wollmann T, Isert D, Limbert M, Schrinner E, Seibert G, Bauernfeind A, Jungwirth R, Wilhelm R, et al.

J Antibiot (Tokyo). 1992 Apr;45(4):521-6.

24.

RU 29 246, the active compound of the cephalosporin-prodrug-ester HR 916. I. Antibacterial activity in vitro.

Bauernfeind A, Jungwirth R, Eberlein E, Klesel N, Adam F, Isert D, Limbert M, Markus A, Schrinner E, Seibert G.

J Antibiot (Tokyo). 1992 Apr;45(4):505-20.

27.

Selection of antibiotics for treatment and prophylaxis of staphylococcal infections in cystic fibrosis patients.

Bauernfeind A, Przyklenk B, Matthias C, Jungwirth R, Bertele RM, Harms K.

Infection. 1990 Mar-Apr;18(2):126-30.

PMID:
2332248
28.

[Antibacterial activity and beta-lactamase stability of eleven oral cephalosporins].

Bauernfeind A, Jungwirth R, Schweighart S, Theopold M.

Infection. 1990;18 Suppl 3:S155-67. German.

PMID:
2079378
29.

In-vitro activity of meropenem imipenem, the penem HRE 664 and ceftazidine against clinical isolates from West Germany.

Bauernfeind A, Jungwirth R, Schweighart S.

J Antimicrob Chemother. 1989 Sep;24 Suppl A:73-84.

PMID:
2509418
30.

Qualitative and quantitative microbiological analysis of sputa of 102 patients with cystic fibrosis.

Bauernfeind A, Bertele RM, Harms K, Hörl G, Jungwirth R, Petermüller C, Przyklenk B, Weisslein-Pfister C.

Infection. 1987 Jul-Aug;15(4):270-7.

PMID:
3117700
31.

Inactivation of cephalosporins by beta-lactamases of gram-negative rods.

Bauernfeind A, Petermüller C, Jungwirth R.

Infection. 1983;11 Suppl 1:S39-43.

PMID:
6339417
32.

Supplemental Content

Loading ...
Support Center